Posts Tagged ‘COVID-19’
From trauma to giving back: Jason’s Covid recovery mission
From trauma to giving back: Jason’s Covid recovery mission 27 December 2021 Wherever possible, Jason Mageehan has always tried to turn adversity into opportunity – whether arranging client meetings to coincide with dialysis sessions or viewing his kidney transplant operation as a springboard to achieving personal and business goals. Now, therapy to deal with…
Read MoreNew study to investigate how third doses of Covid-19 vaccine protect immunocompromised patients
New study to investigate how third doses of Covid-19 vaccine protect immunocompromised patients 09 December 2021 We are pleased to support researchers at London’s Imperial College in a study to understand how well third doses of vaccine protect immunocompromised patients against Covid-19. The study, known as ‘MELODY’, will involve 36,000 immunocompromised patients across the UK,…
Read MoreJCVI recommends kidney transplant patients receive third Covid-19 vaccine dose
JCVI recommends kidney transplant patients receive third Covid-19 vaccine dose 03 September 2021 The Joint Committee on Vaccination and Immunisation (JCVI) has issued new advice that people with severely weakened immune systems should have a third Covid-19 vaccine dose. Research studies, including one we have supported, have shown that people who are severely immunocompromised are…
Read MoreKidney dialysis patients could benefit from third doses of mRNA Covid-19 vaccines
Kidney dialysis patients could benefit from third doses of mRNA Covid-19 vaccines 13 August 2021 A research study funded by Kidney Research UK with other charities; The National Kidney Federation (NKF), Kidney Wales, the PKD Charity and several Kidney Patient Associations, shows kidney patients who receive in-hospital dialysis treatment for kidney disease produced a greater…
Read MoreThe Kidney Charities Together group strongly recommends that precautions are still taken to remain COVID safe
The Kidney Charities Together group strongly recommends that precautions are still taken to remain COVID safe 13 August 2021 New research published in The Lancet has shown that, unlike the general population, many people who have kidney failure and who are on haemodialysis have a poor antibody response to two doses of covid19 vaccine. The…
Read MoreKidney experts meet to discuss how best to protect kidney patients from Covid-19
Kidney experts meet to discuss how best to protect kidney patients from Covid-19 17 June 2021 On Thursday 17 June, kidney doctors and scientists gathered online to share and discuss the very latest research working out how best to protect kidney patients from Covid-19. At the webinar, hosted by the UK Kidney Association, the British Transplant Society, the Royal Society of Medicine and Kidney…
Read MoreNew study will reveal how well Covid-19 vaccines protect dialysis patients
New study will reveal how well Covid-19 vaccines protect dialysis patients 03 March 2021 Kidney Research UK, the National Kidney Federation (NKF), Kidney Wales and the PKD Charity have joined forces to fund a new research study to discover how well Covid-19 vaccines work in people who go to hospital for their dialysis treatment (haemodialysis).…
Read MoreProtect us from Covid-19 – plea from a kidney patient
Protect us from Covid-19 – plea from a kidney patient 24 February 2021 Farah Mulla has lived more than a decade with lupus nephritis, experiencing huge challenges with her condition and treatment, including recently contracting Covid-19. The 29-year-old from Hackney in East London is anxious that kidney patients are prioritised when it comes to being protected from the pandemic. Farah has welcomed news of the new clinical trial…
Read MoreComing out the other side from Covid-19
Coming out the other side from Covid-19 22 February 2021 Farhan Narwaz had had less than a year to get used to relying on dialysis to survive when he contracted COVID-19. Despite his best preparations, the 34 year old pharmacist from Sutton Coldfield caught the virus and spent 23 days in hospital as a result. …
Read MoreCan a tapeworm drug protect high risk kidney patients from Covid-19?
Can a tapeworm drug protect high risk kidney patients from Covid-19? 22 February 2021 We are helping to fund PROTECT-V, a clinical trial to find out if the drug niclosamide, usually used to treat tapeworms, can prevent Covid-19 infection in vulnerable, high risk kidney patients and reduce the number of people who become seriously ill or die from it. If the trial is successful, it may pave the way for a new…
Read More